Agilvax develops targeted vaccine therapies based on its virus-like particle (VLP) platform technology. Agilvax is a biotechnology company employing a unique vaccine discovery platform to develop safe and efficacious vaccines for infectious diseases and chronic conditions. The platform is based on virus-like particles (VLP) derived from RNA bacteriophages engineered to incorporate novel vaccine components necessary for the rapid identification of successful candidates. It is the only VLP platfor...Show all

Agilvax develops targeted vaccine therapies based on its virus-like particle (VLP) platform technology. Agilvax is a biotechnology company employing a unique vaccine discovery platform to develop safe and efficacious vaccines for infectious diseases ...Show all